BECTON, DICKINSON AND COMPANY Notional Amount of Interest Rate Cash Flow Hedge Derivatives (Deprecated 2013-01-31)
BECTON, DICKINSON AND COMPANY (BDX) had Notional Amount of Interest Rate Cash Flow Hedge Derivatives (Deprecated 2013-01-31) of $0 as of 2012-06-30, per its 10-Q filed 2012-08-06.
Discontinued › Notes › Derivative Instruments and Hedging Activities
us-gaap:NotionalAmountOfInterestRateCashFlowHedgeDerivatives · last filed 2012-11-21
- 2012-06-30: Notional Amount of Interest Rate Cash Flow Hedge Derivatives (Deprecated 2013-01-31) $0.00.
- 2012-03-31: Notional Amount of Interest Rate Cash Flow Hedge Derivatives (Deprecated 2013-01-31) $0.00.
- 2011-12-31: Notional Amount of Interest Rate Cash Flow Hedge Derivatives (Deprecated 2013-01-31) $0.00.
- 2011-09-30: Notional Amount of Interest Rate Cash Flow Hedge Derivatives (Deprecated 2013-01-31) $900.00M.
| Period end | Notional Amount of Interest Rate Cash Flow Hedge Derivatives (Deprecated 2013-01-31) |
|---|---|
| 2012-06-30 | $0.00 10-Q · filed 2012-08-06 |
| 2012-03-31 | $0.00 10-Q · filed 2012-05-03 |
| 2011-12-31 | $0.00 10-Q · filed 2012-02-07 |
| 2011-09-30 | $900.00M 10-K · filed 2012-11-21 |
| 2011-06-30 | $0.00 10-Q · filed 2011-08-02 |
| 2011-03-31 | $0.00 10-Q · filed 2011-05-04 |
| 2010-12-31 | $0.00 10-Q · filed 2011-02-08 |
| 2010-09-30 | $0.00 10-K · filed 2011-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |